Sandrine Accassat Selected Research

Sandrine Accassat Research Topics

5	Venous Thromboembolism 09/2023 - 01/2020
4	Hemorrhage 09/2023 - 09/2013
2	Thrombosis (Thrombus) 11/2023 - 09/2023
2	Neoplasms (Cancer) 11/2023 - 09/2023
2	Transient Ischemic Attack 01/2019 - 01/2018
2	Ischemic Stroke 01/2019 - 01/2018
1	Critical Illness (Critically Ill) 06/2023
1	Infections 06/2023
1	COVID-19 06/2023
1	Peripheral Arterial Disease 12/2021
1	Atrial Fibrillation 12/2021
1	Pulmonary Embolism 01/2020
1	Venous Insufficiency 01/2020
1	Stroke (Strokes) 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2016
1	Thrombocytopenia (Thrombopenia) 12/2016
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2016
1	Embolism (Embolus) 09/2013

6	AnticoagulantsIBA 11/2023 - 12/2016
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2023 - 09/2013
2	Nadroparin (Nadroparin Calcium)IBA 01/2020 - 12/2016
2	Clopidogrel (Plavix)FDA Link 01/2019 - 01/2018
1	Thrombin FDA Link 09/2023
1	Factor Xa (Coagulation Factor Xa)IBA 09/2023
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 09/2023
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 09/2023
1	P-SelectinIBA 01/2018
1	Adenosine Diphosphate (ADP)IBA 01/2018
1	Heparin (Liquaemin)FDA LinkGeneric 12/2016
1	Fondaparinux (Arixtra)FDA Link 09/2013
1	apixabanIBA 09/2013
1	RivaroxabanIBA 09/2013
1	Enoxaparin (Lovenox)FDA LinkGeneric 09/2013